Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Other Operating Expenses (2016 - 2025)

Ironwood Pharmaceuticals (IRWD) has disclosed Other Operating Expenses for 12 consecutive years, with -$252000.0 as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses fell 445.21% to -$252000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $20.3 million through Dec 2025, up 681.22% year-over-year, with the annual reading at $20.3 million for FY2025, 681.22% up from the prior year.
  • Other Operating Expenses hit -$252000.0 in Q4 2025 for Ironwood Pharmaceuticals, down from $2.2 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $1.1 billion in Q2 2023 to a low of -$252000.0 in Q4 2025.
  • Historically, Other Operating Expenses has averaged $105.9 million across 3 years, with a median of $2.1 million in 2024.
  • Biggest YoY gain for Other Operating Expenses was 13650.0% in 2025; the steepest drop was 445.21% in 2025.
  • Year by year, Other Operating Expenses stood at $5.6 million in 2023, then plummeted by 98.7% to $73000.0 in 2024, then plummeted by 445.21% to -$252000.0 in 2025.
  • Business Quant data shows Other Operating Expenses for IRWD at -$252000.0 in Q4 2025, $2.2 million in Q3 2025, and -$250000.0 in Q2 2025.